INS and metabolic dysfunction-associated steatohepatitis: However, our analysis of fasting insulin levels indicated that additional clinical variables should be assessed to obtain a more comprehensive evaluation of the effects of TZD treatment on insulin sensitivity in NASH patients, and suggested that including diet control, exercise, and additional insulin-sensitizing drugs in TZD treatment regimens may be beneficial for reducing IR in NASH patients.